Events

Protalix BioTherapeutics Fiscal Year 2025 Financial and Business Results Conference Call

March 18, 2026 8:00 AM EDT

Webcast

Protalix Biotherapeutics Third Quarter 2025 Financial and Business Results Conference Call

November 13, 2025 8:00 AM EST

Webcast

Q3 Investor Summit

September 16, 2025 10:30 AM EDT

Webcast

H.C. Wainwright 27th Annual Global Investment Conference

September 8, 2025 3:30 PM EDT

Protalix Biotherapeutics Second Quarter 2025 Financial and Business Results Conference Call

August 14, 2025 8:30 AM EDT

Webcast

3rd Annual H.C. Wainwright BioConnect Investor Conference

May 20, 2025 4:30 PM EDT

Webcast

Protalix Biotherapeutics First Quarter 2025 Financial and Business Results Conference Call

May 9, 2025 8:30 AM EDT

Webcast

iAccess Alpha Virtual Best Ideas Spring Conference 2025

March 25, 2025 12:00 PM EDT

Webcast

Chiesi Global Rare Diseases Announces Multiple Presentations on pegunigalsidase alfa and Fabry Disease at the 21st Annual WORLDSymposium™ Research Meeting

March 18, 2025

Protalix BioTherapeutics Fiscal Year 2024 Financial and Business Results Conference Call

March 17, 2025 8:30 AM EDT

Webcast

Protalix Therapeutics’ CEO, Dror Bashan, Interviewed by Proactive

January 23, 2025

Protalix Third Quarter 2024 Financial and Business Results Conference Call

November 14, 2024 8:30 AM EST

Webcast

Protalix BioTherapeutics to Present at the Life Sciences Investor Forum

September 19, 2024 12:00 PM EDT

Webcast

Protalix BioTherapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

September 11, 2024 12:30 PM EDT

Protalix Second Quarter 2024 Financial and Business Results Conference Call

August 14, 2024 8:30 AM EDT

Webcast

In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout

June 26, 2024 8:30 AM EDT

Webcast

Protalix BioTherapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference

August 9, 2023 3:30 PM EDT

Webcast